ARTICLE | Clinical News
Hoffmann-La Roche Ltd. regulatory update
April 15, 2013 7:00 AM UTC
Roche's Xenical (orlistat) to treat obesity will be reviewed on May 14 by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee. Xenical, which blocks the absorption of fat from the diet, h...